Search
for

    Sort by

    Research 631–660 of 776

    1. Effects of biomaterials derived from germinated hemp seeds for stressed hair stem cells and immune cells 2024
    2. Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata Dermatologic therapy · 2024
    3. Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth Cutis · 2023
    4. 056 IKZF1 and IKAROS overexpression contributes to the pathogenesis of alopecia areata 2023
    5. Effective treatment of alopecia universalis with oral tofacitinib: A case report Our Dermatology Online · 2021
    6. 870 Y27632 promotes proliferation via EGFR signaling in a newly isolated and characterized human primary sebocyte cell line Journal of Investigative Dermatology · 2019
    7. The Good and Bad News About New Drugs for Treating Alopecia Areata 2017
    8. Mesenchymal-epidermal interactions in hair follicle cycling and regeneration 2015
    9. Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia? International Journal of Dermatology · 2021
    10. Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis JAAD case reports · 2019 · 19 citations
    11. Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases Pharmaceutics · 2020 · 15 citations
    12. Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial The Journal of Dermatology · 2025 · 4 citations
    13. Off-Label Treatment of Alopecia Areata—Retrospective Study Biomedicines · 2026
    14. Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients Indian Journal of Dermatology Venereology and Leprology · 2025
    15. <i>IKZF1</i> and Ikaros Overexpression Results in Alopecia Areata‐Like Phenotype in Mice Experimental Dermatology · 2025
    16. Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study Dermatology and therapy · 2023
    17. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management Clinical Reviews in Allergy & Immunology · 2021 · 290 citations
    18. Understanding, recognizing, and managing toxicities of targeted anticancer therapies Ca · 2013 · 278 citations
    19. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial The Lancet · 2023 · 227 citations
    20. Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier Trends in immunology · 2017 · 181 citations
    21. Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak Viruses · 2020 · 170 citations
    22. Hair follicle immune privilege and its collapse in alopecia areata Experimental dermatology · 2020 · 134 citations
    23. Thou shall not heal: Overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment Advanced Drug Delivery Reviews · 2023 · 90 citations
    24. Understanding autoimmunity of vitiligo and alopecia areata 2016 · 74 citations
    25. Dupilumab in Inflammatory Skin Diseases: A Systematic Review Biomolecules · 2023 · 72 citations
    26. A Review of Edible Jujube, the Ziziphus jujuba Fruit: A Heath Food Supplement for Anemia Prevalence Frontiers in Pharmacology · 2020 · 72 citations
    27. Alopecia Areata: Current Treatments and New Directions American Journal of Clinical Dermatology · 2023 · 57 citations
    28. Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options? Journal of dermatological science · 2016 · 56 citations
    29. Frontiers in alopecia areata pathobiology research 2019 · 55 citations
    30. SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion Viruses · 2022 · 52 citations